 "Apollo Hospitals has been investing big in infrastructure and bringing in advanced technologies such as Proton Therapy for cancer treatment, which has resulted in a higher debt")
Shares of Apollo Hospitals Enterprises hit a new record high of Rs 4,264, ralling 5 per cent on the BSE in the intra-day trade on Monday, after the company reported a strong 31 per cent quarter on quarter (QoQ) growth in consolidated revenue at Rs 3,760 crore for the quarter ended June 2021 (Q1FY22). On a year-on-year (YoY) basis, consolidated revenues rose 73 per cent from Rs 2,172 crore.
The healthy revenue growth was mainly driven by hospital segment, which grew 26.2 per cent QoQ to Rs 1,941 crore, while revenue from the pharmacy distribution segment grew 35 per
The healthy revenue growth was mainly driven by hospital segment, which grew 26.2 per cent QoQ to Rs 1,941 crore, while revenue from the pharmacy distribution segment grew 35 per
